Long-Term Effects of In Utero Antiretroviral Exposure: Systolic and Diastolic Function in HIV-Exposed Uninfected Youth

Vitor Guerra, Erin C Leister, Paige L Williams, Thomas J Starc, Steven E Lipshultz, James D Wilkinson, Russell B Van Dyke, Rohan Hazra, Steven D Colan, Vitor Guerra, Erin C Leister, Paige L Williams, Thomas J Starc, Steven E Lipshultz, James D Wilkinson, Russell B Van Dyke, Rohan Hazra, Steven D Colan

Abstract

The aim of this study was to evaluate the association of in utero exposure to highly active antiretroviral therapy (HAART) with left ventricular (LV) function and structure in HIV-exposed uninfected (HEU) children. A prospective, multisite cohort study in HEU children was conducted by the Pediatric HIV/AIDS Cohort Study (PHACS). Echocardiographic measures of LV systolic and diastolic function and cardiac structure were obtained from HEU subjects aged ≥6 years enrolled in the PHACS Surveillance Monitoring of ART Toxicities study. Echocardiographic Z-scores were calculated using normative data from an established reference cohort. We used adjusted linear regression models to compare Z-scores for echocardiographic measures from HEU children exposed in utero to HAART with those exposed to non-HAART, adjusting for demographic and maternal health characteristics. One hundred seventy-four HEU subjects with echocardiograms and maternal ARV information were included (mean age 10.9 years; 48% male, 56% black non-Hispanic). Among 156 HEU youth with any ARV exposure, we observed no differences in Z-scores for LV systolic function measures between youth exposed in utero to HAART (39%) and HAART-unexposed youth in either unadjusted or adjusted models. In adjusted models, those exposed to HAART had significantly lower mitral late diastolic inflow velocities (adjusted mean Z-score = 0.00 vs. 0.52, p = .04) and significantly higher adjusted mean LV mass-to-volume ratio Z-scores (adjusted mean Z-score = 0.47 vs. 0.11, p = .03) than HAART-unexposed youth. Uninfected children with perinatal exposure to HAART had no difference in LV systolic function. However, small but significant differences in LV diastolic function and cardiac structure were observed, suggesting that continued monitoring for cardiac outcomes is warranted in this population.

Figures

FIG. 1.
FIG. 1.
Adjusted echocardiographic Z-score means by in utero HAART exposure.

References

    1. Lipshultz SE, Easley KA, Orav EJ, et al. : Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med 2000;343:759–766
    1. Blanche S, Tardieu M, Rustin P, et al. : Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999;354:1084–1089
    1. Lipshultz SE, Shearer WT, Thompson B, et al. : Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study). J Am Coll Cardiol 2011;57:76–85
    1. Cade WT, Waggoner AD, Hubert S, Krauss MJ, Singh GK, Overton ET: Reduced diastolic function and left ventricular mass in HIV-negative preadolescent children exposed to antiretroviral therapy in utero. AIDS 2012;26:2053–2058
    1. Lipshultz SE, Williams PL, Wilkinson JD, Leister EC, Van Dyke RB, Shearer WT, et al. ; for the Pediatric HIV/AIDS Cohort Study (PHACS). Cardiac status of HIV-infected children treated with long-term combination antiretroviral therapy: Results from the Adolescent Master Protocol of the NIH Multicentre Pediatric HIV/AIDS Cohort study (PHACS). JAMA Pediatr 2013;167:520–527
    1. Griner R, Williams P, Read JS, et al. ; for the Pediatric HIV/AIDS Cohort study. In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States. AIDS Pat Care STDs 2011;25:385–394
    1. Lipshultz SE, Easley KA, Orav EJ, et al. : Cardiovascular status of infants and children of women infected with HIV-1 (P2C2 HIV): A cohort study. Lancet 2002;360:368–373
    1. Colan SD: Normal echocardiographic values for cardiovascular structures. In: Echocardiography in Pediatric and Congenital Heart Disease (Lai WW, Cohen MS, Geva T, Mertens L, eds.) Wiley-Blackwell, West Sussex, 2009, Appendix 1, pp. 765–785
    1. Foster C, Lyall H: HIV and mitochondrial toxicity in children. J Antimicrob Chemother 2008;61:8–12
    1. Foster BJ, Mackie AS, Mitsnefes M, Ali H, Mamber S, Colan SD: A novel method of expressing left ventricular mass relative to body size in children. Circulation 2008;117:2769–2775
    1. Thomas JD, Weyman AE: Echo Doppler evaluation of left ventricular diastolic function: Physics and physiology. Circulation 1991;84:977–990
    1. Nagueh SF, Kopelen HA, Lim DS, et al. : Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 2001;104:128–130
    1. Grandi AM.Nicolini E.Giola M, et al. : Left ventricle remodeling in asymptomatic HIV infection on chronic HAART: Comparison between hypertensive and normotensive subjects with and without HIV infection. J Human Hypertens 2012;26:570–576
    1. Lipshultz SE, Lipsitz SR, Sallan SE, Dalton VM, Mone SM, Gelber RD, Colan SD: Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 2005;23:2629–2636
    1. Shah I, Prabhu SS, Sumitra V, Shashikiran HS: Cardiac dysfunction in HIV infected children. Indian Pediatr 2005;42:146–149
    1. Lipshultz S, Easley K, Orav E, Kaplan S, et al. : Cardiac dysfunction and mortality in HIV-infected children. The prospective P2C2 HIV Multicenter Study. Circulation 2000;102:1542–1548
    1. Cunha M, Siqueira A, Santos S, Abreu T, et al. : AIDS in childhood: Cardiac involvement with and without triple combination antiretroviral therapy. Arq Bras Cardiol 2008;90:11–17
    1. Tan YT, Wenzelburger F, Lee E, et al. : The pathophysiology of heart failure with normal ejection fraction: Exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. J Am Coll Cardiol 2009;54:36–46
    1. Desai AS: Heart failure with preserved ejection fraction. Time for a new approach? J Am Coll Cardiol 2013;62:272–273

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir